CA930305A - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
CA930305A
CA930305A CA077836A CA77836A CA930305A CA 930305 A CA930305 A CA 930305A CA 077836 A CA077836 A CA 077836A CA 77836 A CA77836 A CA 77836A CA 930305 A CA930305 A CA 930305A
Authority
CA
Canada
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA077836A
Inventor
S. Dwight Joseph
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp
Original Assignee
Pfizer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp filed Critical Pfizer Corp
Application granted granted Critical
Publication of CA930305A publication Critical patent/CA930305A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
CA077836A 1969-03-20 1970-03-19 Pharmaceutical compositions Expired CA930305A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1467169A GB1291282A (en) 1969-03-20 1969-03-20 Improvements in pharmaceutical compositions

Publications (1)

Publication Number Publication Date
CA930305A true CA930305A (en) 1973-07-17

Family

ID=10045477

Family Applications (1)

Application Number Title Priority Date Filing Date
CA077836A Expired CA930305A (en) 1969-03-20 1970-03-19 Pharmaceutical compositions

Country Status (6)

Country Link
BE (1) BE747657A (en)
CA (1) CA930305A (en)
DE (1) DE2013040A1 (en)
ES (1) ES377723A1 (en)
FR (1) FR2035119B1 (en)
GB (1) GB1291282A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2211019C3 (en) * 1972-03-08 1980-08-28 Bayer Ag, 5090 Leverkusen Oral penicillin flavor enhancing formulations
US4235900A (en) * 1978-11-15 1980-11-25 E. R. Squibb & Sons, Inc. Cephradine compositions
EP0091502A1 (en) * 1982-04-13 1983-10-19 Asahi Kasei Kogyo Kabushiki Kaisha A pharmaceutical preparation of cephalosporin for rectal administration

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB794798A (en) * 1955-09-22 1958-05-07 Nathaniel Mandel Elias Pharmaceutical compositions

Also Published As

Publication number Publication date
FR2035119A1 (en) 1970-12-18
BE747657A (en) 1970-09-21
DE2013040A1 (en) 1970-11-26
ES377723A1 (en) 1972-10-16
GB1291282A (en) 1972-10-04
FR2035119B1 (en) 1974-08-30

Similar Documents

Publication Publication Date Title
CA952025A (en) Compositions cosmetiques deodorisantes micro-encapsulees
CA967486A (en) Compositions decolorantes utilisables en cosmetique
CA930306A (en) Pharmaceutical compositions
CA965008A (en) Compositions anti-seborrheiques et antiacneiques
CA934488A (en) Compositions soufrees
CA965010A (en) Compositions antiseborrheiques
CA930305A (en) Pharmaceutical compositions
AU2085570A (en) Rubber-polyester compositions
AU1048070A (en) Pharmaceutical composition
CY845A (en) Antiineectious pharmaceutical compositions
ZA704998B (en) Pharmaceutical compositions
AU435541B2 (en) Pharmaceutical compositions
AU442181B2 (en) Pharmaceutical compositions
CA807196A (en) Pharmaceutical compositions
AU445199B2 (en) Antiinfectious pharmaceutical compositions
AU439713B2 (en) Pharmaceutical compositions
CA830474A (en) Pharmaceutical composition
AU5978169A (en) Pharmaceutical compositions
AU1548470A (en) Antiinfectious pharmaceutical compositions
AU1838870A (en) Pharmaceutical compositions
AU6227569A (en) Pharmaceutical compositions
CA829875A (en) Pharmaceutical compositions containing 1-methyl-4-phenyl-4-piperidinol
ZA695903B (en) Pharmaceutical compositions
CA816173A (en) 1-phenoxy-3-alkylaminopropanols and pharmaceutical compositions
CA815578A (en) Polyepoxide-polyester compositions